10/18/2024

Janusmed sex and gender

Janusmed sex and gender – Chlorthalidone

Janusmed Sex and Gender is a knowledge database providing information on sex and gender aspects of drug treatment. The knowledge database is primarily intended to be used by physicians and healthcare professionals. The texts are general and should not be considered as treatment guidelines. The individual patient’s physician is responsible for the patient’s drug treatment.

Back to index
A A
A A

Chlorthalidone

Chlorthalidone

Class : A

  1. Oparil S, Davis BR, Cushman WC, Ford CE, Furberg CD, Habib GB et al. Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. Hypertension. 2013;61:977-86.
  2. Furberg CD, Black DM. The systolic hypertension in the elderly pilot program: methodological issues. Eur Heart J. 1988;9:223-7.
  3. Dhalla IA, Gomes T, Yao Z, Nagge J, Persaud N, Hellings C et al. Chlorthalidone versus hydrochlorothiazide for the treatment of hypertension in older adults: a population-based cohort study. Ann Intern Med. 2013;158:447-55.
  4. Hygropax (klortalidon). Summary of Product Characteristics. Swedish Medical Products Agency [updated 2017-05-16, cited 2019-03-11].
  5. Perry HM, Jensen J, Kaiser FE, Horowitz M, Perry HM, Morley JE. The effects of thiazide diuretics on calcium metabolism in the aged. J Am Geriatr Soc. 1993;41:818-22.
  6. Läkemedelsstatistik. Stockholm: Socialstyrelsen. 2018 [cited 2019-03-08.]